Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
Doctors don’t care about innovation seal
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Dec 16, 2014 16:55:32
“The company wants us to talk about it, but doctors would not listen to it at all.” A pharmaceutical sales representative say that most of the doctors don’t care about whether a pharmaceutical company has the government’s seal of innovation or not.

The Ministry of Health and Welfare recently added five more companies as “Innovative Pharmaceutical Companies”, to the previous list of forty-one companies. Some pharmaceutical companies like to use this recognition for marketing, but doctors don’t know what that recognition means.”

A pharmaceutical sales rep said, “Doctors just don’t care. They don’t know the definition of an innovative pharmaceutical company recognized by the government. They can’t tell the difference.”

A primary care physician in Kangnam said, “The government picked some companies and gave the innovation seal, based on R&D efforts and productivity. It doesn’t affect their product line. We don’t have to care about it.”

Other doctor said, “A sales rep came and started talking about the government’s innovation seal. I don’t know what that is, so I interrupted him and changed the subject.”
Reply 0
Name Password
Popular News
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com